Rinkey Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Sell
229
-108
-32% -$110K 0.06% 106
2026
Q1
$310K Sell
337
-20
-6% -$20.3K 0.08% 96
2025
Q4
$384K Buy
+357
New +$341K 0.1% 89
2025
Q2
Sell
-265
Closed -$219K 106
2025
Q1
$219K Hold
265
0.07% 91
2024
Q4
$205K Buy
+265
New +$219K 0.07% 87

Other funds holding LLY

Rinkey Investments's LLY Position: Q2 2026 in Review

Rinkey Investments reduced its Eli Lilly (LLY) stake by 32% in Q2 2026, selling an estimated $110K and leaving 229 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #106.

Rinkey Investments first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $384K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rinkey Investments held 229 shares of Eli Lilly worth $275K as of Q2 2026.
  • Rinkey Investments sold 108 Eli Lilly shares in Q2 2026, an estimated $110K.
  • Eli Lilly made up 0.06% of Rinkey Investments's portfolio in Q2 2026, its #106 holding.
  • Rinkey Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Rinkey Investments's Eli Lilly position peaked at $384K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rinkey Investments's 13F filing for Q2 2026, filed 20 Jul 2026.